In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia
2007 ◽
Vol 33
(7)
◽
pp. 1642-1652
◽
2009 ◽
Vol 157
(1)
◽
pp. 44-54
◽
Keyword(s):
1997 ◽
Vol 122
(3)
◽
pp. 469-476
◽
2011 ◽
Vol 164
(7)
◽
pp. 1847-1856
◽
2005 ◽
Vol 16
(Supplement 1)
◽
pp. S71
1997 ◽
Vol 7
◽
pp. S276-S277
◽
Keyword(s):
2003 ◽
Vol 46
(5)
◽
pp. 670-673
◽
2002 ◽
Vol 302
(3)
◽
pp. 1089-1095
◽
2004 ◽
Vol 313
(1)
◽
pp. 293-301
◽